Hidradenitis Suppurativa (HS): Staging Considerations and Unmet Needs

Author(s):

An expert on hidradenitis suppurativa (HS) provides an overview of the Hurley staging system and discusses unmet needs in the overall treatment landscape.

EP: 1.Signs and Symptoms of Hidradenitis Suppurativa (HS)

EP: 2.Epidemiology and Impact of Hidradenitis Suppurativa

EP: 3.The Pathophysiology of Hidradenitis Suppurativa

EP: 4.Differential Diagnosis When Considering Hidradenitis Suppurativa in a Patient

EP: 5.Overview of the Hurley Staging System for Hidradenitis Suppurativa

EP: 6.Comorbidities and Coordinating Care Between Specialists in Hidradenitis Suppurativa

EP: 7.Hidradenitis Suppurativa: Addressing the Psychosocial Impact and Hospitalization Rate

EP: 8.The Impact of Hidradenitis Suppurativa on Families

Now Viewing

EP: 9.Hidradenitis Suppurativa (HS): Staging Considerations and Unmet Needs

EP: 10.The Role of Treatment Guidelines for HS

EP: 11.Biologic Therapies for Hidradenitis Suppurativa

EP: 12.Recent Data on Bimekizumab for Hidradenitis Suppurativa

EP: 13.Ongoing Research in Hidradenitis Suppurativa

EP: 14.Managing Pain in Patients with Hidradenitis Suppurativa

EP: 15.The Role of Surgery in Hidradenitis Suppurativa

EP: 16.Optimizing Multidisciplinary Care of Patients with Hidradenitis Suppurativa

Video content above is prompted by the following questions:

How does current treatment of HS correlate to the Hurley staging system?
What are the unmet needs for the treatment of HS?

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!